LHM Inc. Acquires 39,828 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

LHM Inc. lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 106.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 77,242 shares of the exchange traded fund’s stock after purchasing an additional 39,828 shares during the quarter. SPDR S&P Biotech ETF comprises approximately 3.0% of LHM Inc.’s investment portfolio, making the stock its 4th biggest position. LHM Inc. owned 0.10% of SPDR S&P Biotech ETF worth $7,161,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Avoro Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after buying an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in shares of SPDR S&P Biotech ETF by 1.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after buying an additional 18,202 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after buying an additional 391,333 shares during the period. Finally, Bessemer Group Inc. lifted its stake in SPDR S&P Biotech ETF by 1.7% during the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after acquiring an additional 15,794 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $98.80 on Tuesday. The stock has a market capitalization of $7.53 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a 50-day moving average of $98.94 and a 200 day moving average of $93.97. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.